SHSang Hee Ha

Sang Hee Ha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sang Hee Ha has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Declining Stroke Incidence, Rising Stroke Burden: The New Epidemiology of Stroke in an Aging Korea

    by Sang Hee Ha, Bum Joon Kim

    Ha SH, et al. Korean Circ J. 2027 ;57:e70. https://doi.org/10.4070/kcj.2026.0370

  • Acute Kidney Injury After Intensive Blood Pressure Lowering Following Successful Endovascular Thrombectomy

    by Jae Wook Jung, Hee Byung Koh, Young Dae Kim, JoonNyung Heo, Hyungwoo Lee, Byung Moon Kim, Dong Joon Kim, Na-Young Shin, Sungwook Yu, Seong Hwan Ahn, et al.

    BACKGROUND: The effect of postthrombectomy blood pressure (BP) management on the development of acute kidney injury (AKI) in patients with acute ischemic stroke remains largely unexplored. METHODS: This secondary analysis of the OPTIMAL-BP trial (Outcome in Patients Treated With Intra-Arterial Thrombectomy-Optimal Blood Pressure Control) included patients with acute ischemic stroke due to large-vessel occlusion who achieved successful endovascular thrombectomy and had a systolic BP ≥140 mm Hg. Patients were randomized to intensive (target systolic BP <140 mm Hg) or conventional (target systolic BP 140–180 mm Hg) BP management for 24 hours. The outcomes were AKI within 7 days and within 2 days, defined according to the Kidney Disease: Improving Global Outcomes criteria. In addition, we examined the associations between AKI and functional independence at 3 months, defined as a modified Rankin Scale score of 0 to 2. Multivariable logistic regression analyses were performed with adjustment for age, sex, time from stroke onset to enrollment, baseline National Institutes of Health Stroke Scale score, and baseline estimated glomerular filtration rate. RESULTS: Of 306 patients, 19 were excluded, and 287 patients were included in this analysis (mean age, 73.2 years; 117 [40.8%] women). AKI within 7 days occurred more frequently in the intensive management group than in the conventional group (20/147 [13.6%] versus 9/140 [6.4%]; adjusted odds ratio, 2.54 [95% CI, 1.10–6.35]). Most AKI events were stage 1 (20/29 [69.0%]). Early AKI within 2 days was also more common with intensive BP management. Patients with AKI had significantly lower rates of functional independence (4/29 [13.8%] versus 126/257 [49.0%]; adjusted odds ratio, 0.19 [95% CI, 0.05–0.55]) and higher stroke-related mortality at 3 months (11/29 [37.9%] versus 8/257 [3.1%]; adjusted odds ratio, 13.8 [95% CI, 4.14–49.64]). In a sensitivity analysis with equal creatinine ascertainment, the association with 48-hour AKI did not reach statistical significance (7/76 [9.2%] versus 2/66 [3.0%]; adjusted odds ratio, 4.20 [95% CI, 0.83–32.6]), although the absolute risk difference remained directionally consistent. CONCLUSIONS: Intensive BP lowering after successful endovascular thrombectomy was associated with a higher risk of AKI, even when kidney injury was predominantly mild. In addition, AKI was associated with worse neurological outcomes. These findings suggest that AKI is an important marker of systemic hemodynamic vulnerability after aggressive postendovascular thrombectomy BP lowering. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04205305.

  • Intensive Versus Conventional Blood Pressure Lowering After Successful Endovascular Thrombectomy: OPTIMAL-BP 1-Year Outcomes

    by Jae Wook Jung, Young Dae Kim, JoonNyung Heo, Hyungwoo Lee, Byung Moon Kim, Dong Joon Kim, Na-Young Shin, Haram Joo, Sungwook Yu, Seong Hwan Ahn, et al.

    BACKGROUND: Intensive blood pressure (BP) lowering after successful reperfusion has resulted in short-term harm in acute ischemic stroke. However, it remains unclear whether these adverse effects persist over the long term. METHODS: The OPTIMAL-BP (Outcome in Patients Treated With Intra-Arterial Thrombectomy–Optimal Blood Pressure Control) was a phase 3, multicenter, prospective, open-label, blinded end point, randomized controlled trial with 19 centers throughout South Korea. Patients who underwent endovascular thrombectomy for acute ischemic stroke caused by large vessel occlusion, achieved successful reperfusion of the occluded artery, and exhibited elevated BP (systolic BP ≥140 mm Hg) on 2 measurements obtained 2 minutes apart within 2 hours after recanalization were randomly assigned to receive intensive BP management (systolic BP target P =0.051). Consistent findings were observed in the per-protocol analysis (41.1% versus 54.7%; adjusted odds ratios, 0.56 [95% CI, 0.32–0.97]; P =0.040). One-year mortality and distribution of modified Rankin Scale changes from 3 months to 1 year did not differ between groups. CONCLUSIONS: Intensive BP lowering targeting a systolic BP of <140 mm Hg resulted in worse functional outcomes at 1 year compared with conventional BP management. These randomized data suggest that early postthrombectomy BP management has durable effects on recovery and support current recommendations against intensive BP lowering. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04205305.


  • Open Access

    Initial diagnosis and management of acute ischemic stroke: updates and future directions

    by Sang Hee Ha, Sujin Koo, Seung Min Kim, Jae Young Park, Seung Eun Lee, Bum Joon Kim

    Outcomes in acute ischemic stroke (AIS) depend critically on rapid and accurate early diagnosis in the emergency department. Traditional prehospital tools and large vessel occlusion–focused scales facilitate triage but have limited capacity to distinguish ischemic from hemorrhagic stroke, a distinction essential for acute-phase treatment decisions. Recent advances include mobile stroke units equipped with computed tomography (CT), point-of-care laboratories, and telemedicine systems, as well as the emergence of biomarkers that enable field-based diagnosis and faster initiation of therapy. In-hospital imaging strategies incorporating CT, CT perfusion, and magnetic resonance imaging (MRI)-based tissue clocks have expanded eligibility for endovascular thrombectomy to include patients with large-core infarction or unclear-onset wake-up strokes. Prolonged cardiac monitoring and high-resolution vessel wall MRI have improved the detection of embolic sources and high-risk atherosclerotic plaques. Artificial intelligence now supports rapid imaging interpretation, workflow optimization, and treatment selection. Tenecteplase, a novel thrombolytic, provides a practical alternative to alteplase with comparable safety and efficacy, while post-thrombectomy management emphasizes individualized blood pressure control. In patients with minor stroke or high-risk transient ischemic attack, short-term dual antiplatelet therapy reduces early recurrence, and early initiation of lipid-lowering agents after AIS may stabilize vulnerable plaques and enhance vascular outcomes. Collectively, these innovations represent a shift toward integrated, time-sensitive, and precision-based AIS care spanning prehospital assessment, emergency department management, and post-reperfusion management.


  • Open Access

    Association between endothelial function and early neurological improvement in atrial fibrillation-related ischemic stroke

    by So Young Yang, Sung Hee Ahn, Jeonggeun Moon, Yeong-Bae Lee, Dae-Il Chang, Sang Hee Ha

    Background: Understanding the factors related to early neurological improvement (ENI) is crucial in managing atrial fibrillation-related ischemic stroke (AF-stroke), as ENI indicates better long-term outcomes. We investigated the association between endothelial function, measured via flow-mediated dilation (FMD), and the occurrence of ENI in patients with AF-stroke. Methods: We reviewed patients with acute AF-stroke within 7 days of FMD between April 2019 and April 2025. ENI was defined as a ≥2-point decrease in National Institutes of Health Stroke Scale (NIHSS) or ≥1-point reduction in motor NIHSS items within 24 h in non-thrombolysis patients. For thrombolysis patients, ENI was a ≥8-point reduction or NIHSS 0–1 at 24 h. FMD was measured during hospitalization and expressed as %FMD = (peak diameter − baseline diameter) / Baseline diameter × 100. Multivariable analysis identified the factors associated with ENI and explored their relationship with FMD. Results: Among the 169 patients diagnosed with AF-stroke, 77 (44.4%) experienced ENI. Those with ENI had higher NIHSS (7 [4–13] vs. 2 [1–5], p < 0.001), more confluent (38.7% vs. 25.5%) and scattered with confluent pattern (29.3% vs. 18.1%, p = 0.007), and higher %FMD (6.5% ± 2.5% vs. 5.3 ± 2.2%, p = 0.001). Multivariable analysis revealed a higher initial NIHSS score (adjusted odds ratio [aOR]: 1.329, p < 0.001) and a history of smoking (aOR: 4.532, p = 0.004), and higher %FMD score (aOR: 1.179; p = 0.043) were independently associated with ENI. Subgroup analysis demonstrated a stronger association between high %FMD and ENI in patients with concomitant vascular risk factors, such as hypertension and dyslipidemia. Conclusion: Endothelial function was associated with ENI in patients with AF-stroke.

  • Open Access

    Effect of Induced Hypertension Therapy According to the Mechanism of Single Subcortical Infarction

    by Seung Taek Oh, Jun Young Chang, Dong-Wha Kang, Sun U. Kwon, Sang Hee Ha, Bum Joon Kim

    Oh ST, et al. J Clin Neurol. 2026 Jan;22:e19. https://doi.org/10.3988/jcn.2025.0486

  • Open Access

    Concurrent Use of Contact Aspiration and a Stent Retriever Is Associated With Successful Recanalization in Patients With Cancer-Associated Stroke

    by Soo Jeong, Dongwhane Lee, Hyuk Sung Kwon, Deok Hee Lee, Sang Hee Ha, Jae Young Park, Dong-Wha Kang, Sun U. Kwon, Jong S. Kim, Bum Joon Kim

    Jeong S, et al. J Clin Neurol. 2026 Jan;22(1):50-58. https://doi.org/10.3988/jcn.2025.0216


  • Open Access

    Characteristics and Long‐Term Outcome of Acute Ischemic Stroke in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Compared With Sporadic Small Vessel Occlusion

    by Sang Hee Ha, Jae Young Park, Sung Hee Ahn, Jun Young Chang, Chong Hyun Suh, Hyunjin Kim, Jae‐Sung Lim, Dong‐Wha Kang, Sun U. Kwon, Satoshi Saito, et al.

    Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) often presents as acute ischemic stroke involving cerebral perforators. This study compared the clinical and imaging characteristics and stroke recurrence between patients with CADASIL and those with sporadic small vessel occlusion. Methods: We retrospectively analyzed 70 patients with CADASIL and 70 age‐ and sex‐matched patients with sporadic small vessel occlusion, all of whom experienced acute ischemic stroke. Clinical characteristics and imaging findings were compared, and factors associated with stroke recurrence over a 10‐year follow‐up period were assessed using Cox proportional hazards models. Results: Patients with sporadic small vessel occlusion had more vascular risk factors, whereas patients with CADASIL had more extensive small vessel disease. Acute ischemic stroke lesions in CADASIL were more commonly located in the anterior circulation (78.6% versus 59.4%) and frequently involved the subcortex (28.6% versus 4.3%), centrum semiovale (25.7% versus 0%), and splenium (15.7% versus 0%). In contrast, lesions were less common in the basal ganglia (11.4% versus 32.9%) and brainstem (8.6% versus 24.3%). Multiple simultaneous lesions were more frequent in CADASIL (35.7% versus 7.1%). The 10‐year stroke recurrence rate in CADASIL was 50%, with a hazard ratio (HR) of 7.12 (95% CI, 2.99–16.94; P P <0.001), along with older age, hypertension, elevated initial diastolic blood pressure, periventricular white matter hyperintensities (grade 2), and multiple lesion involvement. Conclusions: Patients with CADASIL patients with acute ischemic stroke have distinct imaging patterns and a significantly higher recurrence risk compared with those with sporadic small vessel occlusion.

  • Open Access

    Factors associated with delayed neurologic improvement after complete endovascular reperfusion in anterior and posterior ischemic stroke

    by Sangil Park, Boseong Kwon, Jun Young Chang, Yunsun Song, Deok Hee Lee, Sang Hee Ha, Bum Joon Kim

    Background: Mechanisms underlying delayed neurological improvement (DNI) after endovascular thrombectomy (EVT) in patients with anterior (ACS) and posterior circulation stroke (PCS) may differ. This study aims to compare the factors associated with DNI in patients with ACS and PCS.Materials and methods: Data of patients who underwent EVT with National Institute of Health Stroke Scale (NIHSS) score more than 6 and achieved successful reperfusion were retrospectively analyzed. DNI was defined as achieving favorable functional outcomes at 90 days, even without early neurological improvement. The factors associated with DNI in patients with ACS and PCS were investigated.Results: A total of 241 patients were included. The proportions of DNI (30.8% vs. 20.0%; p = 0.184) were not significantly different between patients with ACS and PCS. In patients with ACS, absence of atrial fibrillation (aOR = 0.500; 95% CI, 0.264–0.945; p = 0.033), statin use (aOR = 2.842; 95% CI, 1.174–6.882; p = 0.021), lower NIHSS score after 24 h (aOR = 0.816; 95% CI 0.757–0.880; p < 0.001), and shorter onset-to-door time (aOR = 0.999; 95% CI, 0.998–1.000; p = 0.025) were significantly associated with DNI. In patients with PCS, male sex (aOR = 31.809; 95% CI, 1.816–557.074; p = 0.018) and lower initial NIHSS scores (aOR = 0.626; 95% CI, 0.410–0.957; p = 0.031) were significantly associated with DNI.Conclusion: The proportions of DNI were similar in patients with ACS and PCS. However, the factors associated with DNI were different between the two groups.